CA
Charles Antoine Janssen
About Charles Antoine Janssen
Data last updated:
Charles Antoine Janssen has 19 years in corporate governance. Holds Nominee Director and Director roles. Currently with 9 companies, including Sekhmet Technologies Private Limited and Touchkin Eservices Private Limited. Formerly with 6 companies, such as Panacea Medical Technologies Private Limited and Maxxess Technology Private Limited. Engaged in Technology, General Business and more. The 9 current companies with reported revenue have a combined latest revenue of ₹566 Cr; the largest is Qure.Ai Technologies Private Limited at ₹190 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Qure.Ai Technologies Private Limited U74999MH2016PTC283891 | Director | 13 Apr 2022 | 2016 | ₹190 Cr (FY 2025) | Active |
 Neonatal Care & Research Institute Private Limited U85110KA2011PTC060298 | Nominee Director | 29 Sep 2021 | 2011 | ₹134 Cr (FY 2025) | Active |
 Sekhmet Technologies Private Limited U72200HR2015PTC056692 | Nominee Director | 25 Mar 2021 | 2015 | ₹78.09 Cr (FY 2025) | Active |
 Lilac Insights Private Limited U85191MH2011PTC217513 | Director | 14 Jul 2017 | 2011 | ₹77.23 Cr (FY 2025) | Active |
 Touchkin Eservices Private Limited U72200KA2015PTC078356 | Nominee Director | 01 Sep 2022 | 2015 | ₹47.31 Cr (FY 2025) | Active |
 Healthquad Capital Advisors Private Limited U74999DL2019PTC352056 | Director | 13 Nov 2019 | 2019 | ₹21.02 Cr (FY 2025) | Active |
 Neurosynaptic Communications Private Limited U73100KA2002PTC031023 | Nominee Director | 08 Oct 2021 | 2002 | ₹9.78 Cr (FY 2025) | Active |
 Kois India Investment Advisors Private Limited U74999MH2017PTC292186 | Director | 08 Mar 2017 | 2017 | ₹6.24 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Panacea Medical Technologies Private Limited U33112KA1999PTC079963 | Nominee Director | 05 Oct 2021 | 1999 | ₹99.58 Cr (FY 2025) | Active |
 Maxxess Technology Private Limited U74999MH2017PTC289641 | Director | 01 Mar 2018 | 2017 | ₹15,528 (FY 2020) | Under Process Of Striking Off |
 Regency Hospital Limited U85110UP1987PLC008792 | Nominee Director | 28 Feb 2017 | 1987 | ₹562 Cr (FY 2025) | Active |
 Organisation Of Pharmaceutical Producers Of India U91120MH1965GAP013389 | Director | 19 Sep 2008 | 1965 | ₹15.58 Cr (FY 2025) | Active |
| Indo-Belgian Luxembourg Chamber Of Commerce And Industry U91120MH2001NPL132596 | Director | 28 Nov 2007 | 2001 | ₹7.7 Lakh (FY 2023) | Active |
| Ucb India Private Limited U62090MH1959PTC011545 | Managing Director | 28 Feb 2007 | 1959 | ₹32.54 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Charles Antoine Janssen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Charles Antoine Janssen
Charles Antoine Janssen has 19 years in corporate governance. Holds Nominee Director and Director roles. Currently with 9 companies, including Sekhmet Technologies Private Limited and Touchkin Eservices Private Limited. Formerly with 6 companies, such as Panacea Medical Technologies Private Limited and Maxxess Technology Private Limited. Engaged in Technology, General Business and more. The 9 current companies with reported revenue have a combined latest revenue of ₹566 Cr; the largest is Qure.Ai Technologies Private Limited at ₹190 Cr (FY 2025).
Charles Antoine Janssen is associated with 9 companies as Nominee Director and Director, including Qure.Ai Technologies Private Limited (₹190 Cr), Neonatal Care & Research Institute Private Limited (₹134 Cr), Sekhmet Technologies Private Limited (₹78.09 Cr).
Charles Antoine Janssen has expertise in Technology, General Business and other sectors.
Charles Antoine Janssen has 19 years in corporate governance.
By reported revenue, the largest current company of Charles Antoine Janssen is Qure.Ai Technologies Private Limited, with revenue of ₹190 Cr (FY 2025).
The 9 current companies of Charles Antoine Janssen that report revenue have a combined latest revenue of ₹566 Cr.
Charles Antoine Janssen currently holds positions at 9 companies; the 5 largest by reported revenue are Qure.Ai Technologies Private Limited (₹190 Cr), Neonatal Care & Research Institute Private Limited (₹134 Cr), Sekhmet Technologies Private Limited (₹78.09 Cr), Lilac Insights Private Limited (₹77.23 Cr), Touchkin Eservices Private Limited (₹47.31 Cr).